This Solicitation opportunity from Department Of Defense was posted on June 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DIBUCAINE OINTMENT

Closed

SPE2DP-26-T-3646Federal

Submission Closed06/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210

New

DIBBS

AMLODIPINE BESYLATEThe contract pertains to the procurement of Amlodipine Besylate, identified by the National Stock Number 6505-01-387-5458, with a requested quantity of three units. The solicitation is issued by the Defense Logistics Agency under the Department of Defense, reflecting a federally managed purchase request. The solicitation number for this contract is SPE2DP-26-T-3814, and it was posted on June 16, 2026, with a response deadline set for June 22, 2026. This contract is a solicitation type, aiming to acquire Amlodipine Besylate without any specific set-aside status or NAICS code indicated. The place of performance and detailed office address information are not specified, emphasizing the federal nature of the procurement. Interested parties would respond through the designated online portal provided by the Defense Logistics Agency for this acquisition.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by the National Stock Number 6505-01-718-3484. The request involves a quantity of five units under purchase request number 7013890090. This solicitation, numbered SPE2DP-26-T-3808, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The procurement is managed by the Defense Logistics Agency, a federal organization within the Department of Defense, and is intended for performance within the United States, although specific locations are not specified. This contract solicitation falls under federal acquisition and does not indicate any set-aside type or NAICS code, implying it may be open to all qualified bidders. The relevant information is accessible through the Defense Logistics Agency’s online portal, where potential vendors can review and respond to the request. Points of contact are not provided in the available data, indicating that interested parties may need to use the online platform for further inquiries.

Defense Logistics Agency

POSTED

DEADLINE

REHYDRATION SALTS FThe contract pertains to the procurement of rehydration salts, specifically identified by the NSN/Part Number 6505-01-731-2277, with a total quantity of 2 units requested under purchase request number 7015714540. The solicitation, titled "REHYRATION SALTS F," was issued by the Defense Logistics Agency, a component of the Department of Defense, on June 15, 2026. Interested parties were required to submit their responses by the deadline of June 22, 2026. This federal solicitation lacks set-aside designations and NAICS code details, indicating it was open to all qualified bidders. The place of performance details were unspecified, suggesting flexibility or further clarification in subsequent communications. The contract focuses on meeting the agency's need for these medical supplies, likely for use in rehydration treatment scenarios, aligning with the Department of Defense's logistical and operational requirements.

Defense Logistics Agency

POSTED

DEADLINE

ESCITALOPRAM OXALATThe contract pertains to the procurement of Escitalopram Oxalat, identified by NSN/Part Number 6505-01-718-3478, with a purchase request quantity of five units. This solicitation, numbered SPE2DP-26-T-3803, was posted on June 15, 2026, with a response deadline set for June 22, 2026. The contracting agency responsible for this procurement is the Defense Logistics Agency under the Department of Defense. This contract is a federal solicitation with no set-aside type indicated, and no specific NAICS code was assigned. While the precise location for the place of performance and the office address details are not provided, the procurement is handled within the United States. The contract is publicly available for review on the Defense Logistics Agency’s electronic bidding system, allowing eligible vendors to respond within the designated timeframe.

Defense Logistics Agency

POSTED

DEADLINE

PLASMA-LYTE A INJECThe contract involves the procurement of PLASMA-LYTE A INJEC, identified by NSN 6505-01-708-9039, with a total quantity of three units requested under purchase request number 7017120906. The solicitation, designated SPE2DP-26-T-3802, was posted on June 15, 2026, by the Defense Logistics Agency under the Department of Defense. The response deadline for the solicitation is June 22, 2026, indicating a brief window for submissions. This contract is categorized as a solicitation with no specified type of set-aside or applicable NAICS code, and the performance location details are not provided. The contracting agency is a federal entity focusing on defense logistics, ensuring the procurement supports government operations. Relevant contract information and updates are accessible via the Defense Logistics Agency's procurement platform.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 6 days

AI Contract Overview

The contract pertains to the procurement of DIBUCAINE OINTMENT under solicitation number SPE2DP-26-T-3646, issued by the Defense Logistics Agency, a branch of the Department of Defense. The solicitation was posted on June 2, 2026, with a response deadline of June 8, 2026. The contract calls for a quantity of five units of the ointment, corresponding to NSN/Part Number 6505-00-299-9535. The procurement is a federal contract without a specified set-aside designation or NAICS code. The place of performance and specific office address details are not provided in the documentation. The contract facilitates the acquisition of the ointment for defense-related purposes, supporting the medical supply needs within the Department of Defense.

General Info

Procurement of five DIBUCAINE OINTMENT units for Department of Defense by June 8, 2026.

Agency

Department Of Defense → Defense Logistics Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers View NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJun 2

Solicitation

Response DeadlineJun 8

Deadline has passed

Submission Closed

06/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Defense Logistics Agency

ContactsNo contacts available

OfficeUS

Organization / Agency

Department Of Defense → Defense Logistics Agency

Office AddressUS

ContactsNo contact information available

Full Description

DIBUCAINE OINTMENT NSN/Part Number: 6505-00-299-9535 Purchase Request: 7017004624QTY: 5

Pinnacle Systems International IncUEI: M1P3R5T7V9X2CAGE: 5A3C7$31,089,772View Profile

Pinnacle Systems International IncUEI: M1P3R5T7V9X2CAGE: 7P1R4$891,234View Profile

Pinnacle Systems International IncUEI: F9H2D7S5V3A1CAGE: 2W6Y9$7,213,456View Profile

Bluestone Government Services CorpUEI: G4C8E6Y2U0I7CAGE: 2W6Y9$31,089,772View Profile

Bluestone Government Services CorpUEI: G4C8E6Y2U0I7CAGE: 5A3C7$14,562,088View Profile